Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-22

FDA Approved: RYANODEX DANTROLENE SODIUM — Original Application (Eagle Pharmaceuticals, Inc.)

View source ↗

Summary

This FDA entry documents the original approval of Ryanodex Dantrolene Sodium (dantrolene sodium) by Eagle Pharmaceuticals, Inc. for the treatment of malignant h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RYANODEX DANTROLENE SODIUM (DANTROLENE SODIUM)

Snippet

ORIG AP for RYANODEX DANTROLENE SODIUM (DANTROLENE SODIUM)